Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Maravai Lifesciences Up Over 30%, on Pace for Largest Percent Increase in Over a Year -- Data Talk

Maravai Lifesciences Up Over 30%, on Pace for Largest Percent Increase in Over a Year -- Data Talk

Dow JonesDow Jones2026/08/19 14:36

Maravai Lifesciences Holdings, Inc. Class A (MRVI) is currently at $7.46, up $1.73 or 30.05%

--Would be highest close since Nov. 7, 2024, when it closed at $7.84

--On pace for largest percent increase since Aug. 12, 2025, when it rose 30.58%

--Currently up two consecutive days; up 31.43% over this period

--Best two day stretch since the two days ending Aug. 13, 2025, when it rose 33.5%

--Up 13.62% month-to-date

--Up 129.69% year-to-date

--Down 87.69% from its all-time closing high of $60.62 on Aug. 20, 2021

--Up 203.46% from 52 weeks ago (Aug. 20, 2025), when it closed at $2.46

--Would be a new 52-week closing high

--Up 220.39% from its 52-week closing low of $2.33 on Aug. 27, 2025

--Traded as high as $7.70; highest intraday level since Nov. 7, 2024, when it hit $8.14

--Up 34.15% at today's intraday high; largest intraday percent increase since Feb. 23, 2024, when it rose as much as 68.69%

All data as of 10:31:49 AM ET

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

August 19, 2026 10:36 ET (14:36 GMT)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Following Novartis, Novo Nordisk (NVO.US) terminates two cardiovascular clinical trials.

Novo Nordisk (NVO.US) has terminated two additional clinical trials of its experimental cardiovascular drug.

智通财经2026/09/07 11:21
Following Novartis, Novo Nordisk (NVO.US) terminates two cardiovascular clinical trials.